BioCentury | May 23, 2020
Translation in Brief

A three-compound dengue treatment; plus reversing antibiotic resistance, AbCellera-Lilly, reducing cholesterol with CRISPR and COVID cash for Sherlock

...and cholesterol of about 88% and 45%, respectively. Funding to speed Sherlock’s COVID-19 work The Open Philanthropy Project...
...Proprotein convertase subtilisin/kexin type 9 Danielle Kopke, Staff Writer, and Robin Sawka, Biocentury Staff Sherlock Biosciences Inc. Open Philanthropy Project Stanford...
BioCentury | Jun 14, 2019
Emerging Company Profile

Sherlock: Leveraging CRISPR, synthetic biology for diagnostics

...Number of employees: 15 Funds raised: $49 million Investors: Northpond Ventures, Baidu Ventures and the Open Philanthropy Project...
BioCentury | Apr 26, 2019
Financial News

Sherlock adds $14M to series A

...and bringing the biotech's total funding to $49 million. Northpond Ventures, Baidu Ventures and the Open Philanthropy Project...
...launched in March with $35 million in funding, including a $17.5 million non-dilutive grant from Open Philanthropy project...
BioCentury | Mar 21, 2019
Financial News

Sherlock debuts to develop CRISPR diagnostics with IP from Broad, Harvard

...separately or in combination. The $35 million funding includes a $17.5 million non-dilutive grant from Open Philanthropy Project...
Items per page:
1 - 4 of 4
BioCentury | May 23, 2020
Translation in Brief

A three-compound dengue treatment; plus reversing antibiotic resistance, AbCellera-Lilly, reducing cholesterol with CRISPR and COVID cash for Sherlock

...and cholesterol of about 88% and 45%, respectively. Funding to speed Sherlock’s COVID-19 work The Open Philanthropy Project...
...Proprotein convertase subtilisin/kexin type 9 Danielle Kopke, Staff Writer, and Robin Sawka, Biocentury Staff Sherlock Biosciences Inc. Open Philanthropy Project Stanford...
BioCentury | Jun 14, 2019
Emerging Company Profile

Sherlock: Leveraging CRISPR, synthetic biology for diagnostics

...Number of employees: 15 Funds raised: $49 million Investors: Northpond Ventures, Baidu Ventures and the Open Philanthropy Project...
BioCentury | Apr 26, 2019
Financial News

Sherlock adds $14M to series A

...and bringing the biotech's total funding to $49 million. Northpond Ventures, Baidu Ventures and the Open Philanthropy Project...
...launched in March with $35 million in funding, including a $17.5 million non-dilutive grant from Open Philanthropy project...
BioCentury | Mar 21, 2019
Financial News

Sherlock debuts to develop CRISPR diagnostics with IP from Broad, Harvard

...separately or in combination. The $35 million funding includes a $17.5 million non-dilutive grant from Open Philanthropy Project...
Items per page:
1 - 4 of 4